Abstract
LTHOUGH THE TREATMENT OF CANCER IS INCREASingly multimodal, virtually all patients with solid tumors undergo surgery. In breast cancer, survival after mastectomy, or breast-conserving surgery (BCS) and radiotherapy, are equivalent, 1 and both surgical approaches have a negligible risk of major adverse events. Surgical quality performance measures for cancer have generally focused on 30-day morbidity and mortality rates for higher-risk procedures such as pancreatectomy and esophagectomy. 2 Thus, breast surgery has largely been excluded from the cancer surgical procedures for which quality measures have been developed. Indeed, the focus of quality improvement in breast cancer has primarily been on process measures tied to nonsurgical treatments, including systemic therapies and radiation. 3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
